News
Post–COVID-19 lung injury: What we know so far
July 1, 2021
More than 30 million patients have been diagnosed with COVID-19 in the United States and close to half will experience persistent dyspnea.
![1]()
News
Conservative treatment for spontaneous pneumothorax?
June 29, 2021
Is conservative management of moderate to large primary spontaneous pneumothorax an acceptable alternative to interventional treatment?
![1]()
Opinion
Few clinical guidelines exist for treating post-COVID symptoms
June 24, 2021
‘We can prevent many infections from this virus, but we are still left to manage many post-COVID symptoms,’ says Dr. Linda Girgis.
![1]()
News
Tofacitinib shows mortality benefit in patients with COVID-19 pneumonia
June 23, 2021
The Janus kinase inhibitor tofacitinib reduces the risk of both death and respiratory failure in hospitalized adults with COVID-19 pneumonia.
News
Prophylactic anticoagulation tied to lower death rate in COVID
June 18, 2021
Prophylactic use of low-dose anticoagulation to prevent venous thromboembolism was associated with reduced 60-day mortality in patients hospitalized with COVID-19 in Michigan.
News
U.S., international MIS-C studies yield disparate results
June 18, 2021
The two real-world observational studies were published online in The New England Journal of Medicine.
News
COVID-19 death toll higher for international medical graduates
June 11, 2021
These individuals are more likely to work in places where the incidence of COVID-19 is high and in facilities with fewer resources, according to the author of a new paper.
News
Collaborative effort reduces COPD readmissions, costs
June 6, 2021
A joint performance-improvement initiative helped reduce COPD-related ED visits and readmissions within 30 days of a COPD discharge.
![1]()
News
High-flow nasal cannula improves dyspnea in palliative care patients with respiratory failure
June 2, 2021
Does a high-flow nasal cannula improve acute dyspnea in palliative care patients?
![1]()
News
Avoiding excess oxygen in mechanically ventilated patients ‘seems sensible’
June 2, 2021
Future trials “will have to address how a particular [oxygenation] target is both set and achieved in each group of patients, particularly those with specific organ injuries.”




